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ABSTRACT: The glycosylated and halogenated dialkylresorcinol (DAR)
compounds bartolosides A−D (1−4) were recently discovered from
marine cyanobacteria and represent a novel family of glycolipids, encoded
by the brt biosynthetic gene cluster. Here, we report the isolation and
NMR- and MS-based structure elucidation of monoglycosylated bartolo-
sides E−K (5−11), obtained from Synechocystis salina LEGE 06099, a strain
closely related to the cyanobacterium that produces the diglycosylated 2−4.
In addition, a genome region containing orthologues of brt genes was
identiﬁed in this cyanobacterium. Interestingly, the major bartoloside in
S. salina LEGE 06099 was 1 (above 0.5% dry wt), originally isolated from
the phylogenetically distant ﬁlamentous cyanobacterium Nodosilinea sp.
LEGE 06102. Compounds 5−11 are analogues of 1, with diﬀerent alkyl
chain lengths or halogenation patterns. Their structures and the organiza-
tion of the brt genes suggest that the DAR-forming ketosynthase BrtD can
generate structural diversity by accepting fatty acyl-derived substrates of varying length. Compound 9 features a rare midchain
gem-dichloro moiety, indicating that the putative halogenase BrtJ is able to act twice on the same midchain carbon.
Glycolipids are abundant in cyanobacteria and are presentas a functionally relevant component of photosystem I,1
in thylakoid and cytoplasmic membranes where they have a
structural role2 that is also related to thermotolerance,3 and in
the heterocytes, creating a barrier to maintain an anoxic environ-
ment.4 Recently, we have uncovered a new class of glycolipids
from marine cyanobacteria: bartolosides A−D (1−4), which
are mono- or diglycosylated dialkylresorcinols (DARs) with
halogenated alkyl moieties.5 The diglycosylated bartolosides
2−4, produced by the coccoid cyanobacterium Synechocystis
salina LEGE 06155, feature O-linked α-L-rhamnose and
C-linked β-xylose, while the monoglycosylated 1 produced by
Nodosilinea sp. LEGE 06102 has an O-linked β-D-xylosyl moiety.
The biosynthesis of the DAR skeleton of 2−4 involves ﬁrst the
head-to-head condensation of an α,β-unsaturated fatty acyl-
ACP thioester with a β-keto-fatty acyl-ACP thioester (abundant
fatty acyl derivatives in cyanobacterial cells), catalyzed by the
ketosynthase BrtD. This is followed by oxidative aromatization,
catalyzed by the FMN-dependent aromatase BrtC.5 Other
functions encoded in the bartoloside biosynthetic gene
cluster (brt) include glycosyltransferases, a putative halogenase
(BrtJ), and a glycolipid export cassette.5 In assays using human
cancer cell lines, 1 and 2 showed low to mid micromolar
cytotoxicity.5
As part of a bioassay-guided marine biodiscovery eﬀort,
we have followed a cytotoxic midpolarity fraction from one
other S. salina strain (LEGE 06099) and isolated 1 as a major
metabolite, together with the seven minor monoglycosylated
bartolosides E−K, 5−11. We report here on the structure elucida-
tion and biological activity of these compounds. Moreover, a
putative brt gene cluster was identiﬁed in the genome of S. salina
LEGE 06099, and the biosynthesis of mono- and diglycosylated
bartolosides is discussed.
■ RESULTS AND DISCUSSION
Isolation and Structure Elucidation of Monoglycosy-
lated Bartolosides from S. salina LEGE 06099. The marine
cyanobacterium S. salina LEGE 06099, isolated from the intertidal
Received: April 20, 2016
Published: September 28, 2016
Article
pubs.acs.org/jnp
© 2016 American Chemical Society and
American Society of Pharmacognosy 2504 DOI: 10.1021/acs.jnatprod.6b00351
J. Nat. Prod. 2016, 79, 2504−2513
D
ow
nl
oa
de
d 
by
 U
N
IV
ER
SI
D
A
D
E 
D
O
 P
O
RT
O
 0
11
00
 a
t 1
0:
28
:5
0:
99
7 
on
 M
ay
 2
8,
 2
01
9
fro
m
 h
ttp
s:/
/p
ub
s.a
cs
.o
rg
/d
oi
/1
0.
10
21
/a
cs
.jn
atp
rod
.6b
00
35
1.
zone of a rocky beach in Northern Portugal,6 was grown in
multiple 4 L cultures. The corresponding biomass was harvested
by centrifugation and fractionated using vacuum liquid
chromatography (VLC). One of the resulting fractions, eluting
with EtOAc/Hex, 4:1 (v/v), showed cytotoxic activity against
the MG-63, RKO, and T47D human cancer cell lines. Further
fractionation by normal-phase gravity column chromatography
and reversed-phase HPLC yielded pure 1 as a major metabolite,
along with 5 and other minor metabolites, which showed
MS patterns consistent with chlorination. The identity of 1 was
established based on identical NMR, MS fragmentation, and
sugar conﬁguration data of the metabolite isolated from
S. salina LEGE 06099 and of 1 isolated from Nodosilinea sp.
LEGE 06102 (Figure S1, Figure S2, Table S1, Supporting
Information).5 In order to obtain the minor metabolites
in suﬃcient amounts for detailed structural characterization,
S. salina LEGE 06099 was grown in a larger scale, ultimately
yielding 1 (164 mg, 0.58% d.w.), as well as the minor
constituents 6−11.
In our previous work with 1−4, elucidation of the planar
structures, especially of the chlorinated DAR skeleton, required
an integration of NMR, MSn data, and biosynthetic
information.5 In particular, HSQC-TOCSY experiments were
instrumental for the assignment of the chlorinated positions,
MS data informed on the alkyl chain lengths, while an under-
standing of which fatty acid derivatives were involved in the
biosynthesis clariﬁed the relative positions of the alkyl chains.
Hence, as a general strategy to elucidate the structures of 5−11,
we used such previous information on 1−4 as a reference for
comparison. All of the bartolosides herein reported contain a
xylosyl moiety. Given the identical NMR data for this portion
of the molecules with that of 1, we propose that this residue is
β-D-xylopyranosyl for 5−11 as determined for 1.5
Metabolite 5 was found to have the molecular formula
C34H58Cl2O6 on the basis of HRESIMS data, two carbons and
four protons less than compound 1. Analysis of 1H and 13C
APT NMR data in DMSO-d6 quickly revealed that the sugar
and aromatic regions were identical to those in 1. Furthermore,
no additional methyl or methine carbon resonances were
found for 5, compared to 1. This indicated that the diﬀerences
between the two compounds are two alkyl chain methylenes;
to clarify where these diﬀerences were found, we resorted to
HRESIMSn analysis of a dehalogenated, aglycone species formed
in the ionization chamber, as previously observed for 1−4.5
Fragmentation of this species revealed that a C10 chain was
present as a substituent in position 5 of the resorcinol ring
(Figure 1, Figure S3). Closer inspection of the 13C NMR data for
the two compounds revealed that only three methylene carbons
resonating at ∼ δC 26.0−25.6 were found in 5, compared to the
four methylenes C-15, C-19, C-27, and C-31 in 1. Concom-
itantly, one of the methylenes vicinal to the chlorinated position
in 5 was slightly more shielded (δC 37.5) when compared to 1.
In addition, while for 1 two ω-3 carbon resonances at δC 31.1
and 30.7 are observed, in 5 a single ω-3 carbon resonates in this
region. One of the ω-2 carbon signals is also more shielded in 5
(δC 21.7; δC 22.0 for 1). This hinted that the chlorinated methine
was closer to the chain terminus in 5 when compared to 1.
HMBC correlations connecting one of the slightly resolved
methyl triplets to both an ω-3 carbon resonating at δC 28.1
(C-32) and an ω-2 carbon resonating at δC 21.7 (C-33) sup-
ported that chlorination in this chain would be in position ω-5
(Figure 2), thereby establishing the planar structure of com-
pound 5. Of practical importance, the structure elucidation of 5
also clariﬁed that, in 1, the ω-3 carbons in the C12 and C13 chains
resonate at δC 30.7 and 31.1, respectively (in DMSO-d6).
Metabolite 6 was found to have the molecular formula
C37H64Cl2O6 based on HRESIMS analysis, corresponding to
one additional carbon and two protons, when compared to 1.
Comparison of 1D and 2D NMR data (including HSQC-
TOCSY) for 6 and 1 did not reveal discernible diﬀerences,
except for an additional peak in the δ 28.5−28.4 region in the
spectrum of 6, suggesting that an extra aliphatic methylene
would be present in this compound. A smaller additional peak
in the 13C APT spectrum of 6 at δ 31.1 was also observed,
but it lacked clear HSQC or HMBC correlations and was
not considered. HRESIMSn analysis of the in-source-isolated
dechlorinated aglycone of 6 showed that the additional
methylene was present in the C-5 alkyl chain substituent
(Figure 1, Figure S3). The positioning of the Cl atom in this
chain is presumed to be at a six-carbon distance from the
Chart 1
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resorcinol ring, due to the highly similar 1D and 2D NMR data
(in particular HSQC-TOCSY) of 6 and 1.
The HRESIMS-derived molecular formula of metabolite 7
(C36H63ClO6) suggested that this compound could be an
analogue of 1 with a fully aliphatic alkyl chain. In fact, the 1H
NMR data conﬁrmed this hypothesis, with the multiplets for
the chlorinated methine and vicinal methylenes in 7 integrating
for one and four protons, respectively. This was in agreement
with the 13C APT data, with a single carbon resonance at δC
64.8 for a chlorinated methine and two carbon resonances at δC
37.9−37.8 for the vicinal positions. Less shielded resonances
of the methylene vicinal to the benzylic position (C-25) in the
C13 chain (δC 30.7 in 7 and δC 30.6 in 1) and one of the ω-3
carbons (δC 31.3 in 7 and δC 31.1 in 1) formed the basis for
our proposal for a nonhalogenated C13 chain in 7, which is
supported by HRESIMSn analysis (Figure 1, Figure S3).
Metabolite 8 was found to have the molecular formula
C38H66Cl2O6 from the HRESIMS data, corresponding to two
additional carbons and four protons when compared to 1.
No important diﬀerences in the resonances for the aromatic
and xylose residue regions between 8 and 1 were found in 1H
and 13C APT data, nor were additional methyl or methine
resonances found for 8, consistent with two extra methylenes in
the alkyl chains of this compound when compared to 1. Overall,
1D and 2D (including HSQC-TOCSY) NMR data for 8 were
highly similar to those for 1, with the exception of a more
complex aliphatic methylene region in the carbon spectrum of 8,
as expected. A good agreement with the 13C data (δC 38.0−13.5
region) for 25 led us to hypothesize that C12/C15 alkyl chains
would be present in 8, which was conﬁrmed by HRESIMSn
fragmentation analysis of the in-source-formed dechlorinated
aglycone of 8 (Figure 1, Figure S3). Given the similar HSQC-
TOCSY data of 8 and 1 in establishing the connection from
the benzylic position (C-/H2-24) to the chlorinated methine
(C-/H-29) (Figure S4), a ω-10 positioning of the Cl atom was
assigned for 8.
Metabolite 9 was found to have the molecular formula
C36H61Cl3O6 on the basis of HRESIMS data, consistent with an
analogue of 1 bearing an additional chlorine atom. The 1H and
13C APT NMR data in DMSO-d6 of 9 showed resonances for
the aromatic and sugar moieties mostly identical to those of 1,
although slight (<0.03 ppm) diﬀerences were observed for the
sugar and resorcinol exchangeable protons. Integration of the
chlorinated methine multiplet resonating at δH 4.01 indicated
that this corresponded to a single proton, which would be con-
sistent with a gem-dichloro group in the molecule. A multiplet
integrating for four protons at δH 2.19 (H2-28/H2-30) with an
HSQC correlation to two carbons at δC 47.2−47.1 was found
to have no counterpart in the NMR data of 1. A nonprotonated
carbon (δC 97.2, C-29) was HMBC-correlated to the δH 2.19
multiplet, which in turn showed a COSY correlation to a
Figure 1. HRESIMSn analysis of 5−11. (A) For each compound, an
in-source-formed dechlorinated aglycone species was fragmented to
provide information on the length and number of halogens of each
alkyl chain. (B) Annotation of diagnostic m/z values encountered in
the MS/MS analysis for each species. Asterisks indicate tropolone
formation following fragmentation.
Figure 2. Key 2D NMR correlations supporting the proposed chlorine
position in the C-5 alkyl substituent for metabolites 5 and 9.
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multiplet at δH 1.57. An HSQC experiment allowed assignment
of this resonance to two methylene carbons (δC 24.8, 24.5,
C-27/31). These protons were strongly correlated to the C-29
and C-28/30 positions. Overall, this established a midchain
gem-dichloro moiety. HSQC-TOCSY revealed that the H2-24
(δH 2.40) and the H2-28 protons were correlated to C-25
(δC 30.7), while the H2-27 (δH 1.57) and H2-28 protons were
correlated to C-26 (δC 28.2), placing the gem-dichloro group
on the 5-alkyl substituent (Figure S5). HRESIMSn analysis
supported this assignment and indicated that the two alkyl
chains were C12 and C13 (Figure 1, Figure S3). The exact
positioning of the gem-dichlorinated position was established
from the aforementioned HSQC-TOCSY data, from the COSY
correlations of both the H2-25 (δH 1.50) and H2-27 protons to
H2-26 (δH1.31), and from HMBC correlations between C-26
and both H2-25 and H2-27 (Figure 2, Figure S5). Selective 1D
TOCSY experiments with varying mixing times supported
these assignments, as the magnetization from both H2-24 and
H2-28 is propagated to a δH 1.31-centered multiplet (H2-26),
through H2-25 and H2-27, respectively (Figure S5).
From HRESIMS analysis, metabolite 10 was found to have
the molecular formula C34H59ClO6. Due to the low amount
of compound isolated (0.2 mg), we were unable to obtain a
13C spectrum, and both the HMBC and HSQC-TOCSY data
showed limited correlational information. The molecular formula
indicated that 10 could be a shorter chain analogue of 1 with just
one chlorination. This possibility was corroborated by the
identical 1H NMR data in DMSO-d6 for the aromatic and sugar
regions of 10 and 1 and by integrations of one and four protons
for the signals corresponding to the chlorinated methine and
vicinal methylenes, respectively, in 10. Further structural details
were obtained from HRESIMSn analysis. Because only one
chlorination is present, the dehalogenated aglycone isolated in
the ionization chamber that was subject to fragmentation con-
tained an unsaturation in only one of the chains (loss of HCl)
(Figure 1, Figure S3). We could therefore infer chain lengths
from the MS data, as well as which of the two chains contained
the unsaturation. The alkyl chain substituent at C-5 was thus
found to be fully aliphatic and two carbons shorter than the
corresponding alkyl chain in 1 (Figure 1, Figure S3).
Metabolite 11 was found to have the molecular formula
C35H60Cl2O6 from HRESIMS analysis, with one CH2 formula
diﬀerence compared to 1. The 1H and 13C APT NMR data in
DMSO-d6 for 11 and 1 were highly similar, indicating that com-
pound 11 should have one less alkyl chain methylene. HRESIMSn
analysis of 11 was used for further structural inferences.
Fragmentation of the respective in-source-isolated dehalogenated
aglycone species clariﬁed that a C12 chain was a substituent at
position 5 of the resorcinol ring (Figure 1, Figure S3). Given the
similarity in the NMR data, the positioning of the Cl atom is
proposed from the conserved halogenation pattern observed
in the bartolosides (six-carbon distance from the aromatic ring,
exception is compound 5).
The availability of NMR and MS data for 1−4 greatly
facilitated the structure elucidation of bartolosides 5−11.
Still, the precise positioning of the Cl atom in the C-5 alkyl
substituent was only evident for compounds 5 and 9. For
compounds 6, 8, and 11, such positioning is in agreement with
our elucidations of 1−4.5 From our proposed structures, the
chlorination on the C-5 substituent in 5 occurs in a diﬀerent
position than for all other bartolosides (seven carbons away
from the resorcinol ring vs six carbons, respectively), suggesting
that BrtJ is capable of acting on diﬀerent positions. However,
the pronounced chemical shift degeneracy for the aliphatic
methylenes that are more than two carbons away from the
chlorine atom moiety renders Cl positions in both alkyl chains
diﬃcult to diﬀerentiate from NMR (including HSQC-TOCSY)
data. Therefore, structural conﬁrmation of the proposed
bartoloside structures by total synthesis is highly desirable
(also for establishing the absolute conﬁgurations), since these
compounds have eluded all of our crystallization attempts.
Biosynthesis of Bartolosides in S. salina LEGE 06099.
While the two bartoloside-producing S. salina strains are
phylogenetically close (Figure S6), we could not ﬁnd 2−4 in an
organic extract of S. salina LEGE 06099, nor could we ﬁnd 1 or
5−11 in an extract of S. salina LEGE 06155 (Figure S6).
To clarify how these observations translated at the genetic level
and how the structural diversity observed in the compounds
isolated from S. salina LEGE 06099 could be generated, we
studied the biosynthesis of the bartolosides in this strain.
Naturally, we envisioned that its genome would likely harbor a
gene cluster with homology to the diglycosylated bartoloside-
generating brt cluster in S. salina LEGE 06155. To obtain
stronger evidence for this hypothesis prior to genome
sequencing, we used a degenerate PCR strategy to show that
brtC and brtD homologues were indeed found in the genome of
S. salina LEGE 06099, by obtaining an amplicon that spanned
both genes (Figure S8, 82% identity to brtCD in S. salina LEGE
06155). Following genome sequencing and mining, we were
able to identify what, in all likelihood, is the brt gene cluster
in this cyanobacterium (Figure 3). As expected, the cluster is
highly homologous to the S. salina LEGE 06155 brt cluster
(Figure 3, Table S2). However, only two glycosyltransferases
are encoded in the putative brt cluster from S. salina LEGE
06099, as opposed to three such enzymes coded by the S. salina
LEGE 06155 cluster. Given the strong homology between
the glycosyltransferases that are shared by both clusters, it is
unclear whether the two enzymes play a role in the installation
of a single sugar moiety.
A putative halogenase (BrtJ) is present in the two brt
clusters. Genes homologous to brtJ have recently been found in
cyanobacterial biosynthetic gene clusters encoding halogenated
natural products,7,8 and bioinformatics analyses have strongly
suggested that these enzymes are a new type of dimetal
halogenase.5,7 In S. salina LEGE 06099 BrtJ is therefore likely to
carry out the single halogenations on unactivated carbons found
in all bartolosides, but also to give rise to the gem-dichloro group
in 9. This functionality is relatively rare, being found in the
cyanobacterial natural products hectochlorin,9 lyngbyabellins,10,11
Figure 3. Overview of the brt gene clusters in S. salina strains LEGE
06099 and LEGE 06155.
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cyclophanes,12 and columbamide B,7 in the myxobacterial
metabolite chlorotonil A,13 and in a handful of marine-derived
lipids.14 In hectochlorin biosynthesis halogenation is carried out
by a nonheme iron α-ketoglutarate-dependent enzyme (HctB),15
while a FAD-dependent halogenase (CtoA) is thought to install
the Cl atoms found in chlorotonil A.16 Notably, in recent
investigations of columbamide B and carbamidocyclophane
biosyntheses, terminal gem-dichlorination has been suggested
to be performed by BrtJ homologues (ColD/ColE and CabC,
respectively).7,17
Bartoloside A (1) is very abundant in S. salina LEGE 06099,
making up to 0.6% of the total dry weight (d.w.). Such levels
are comparable in magnitude to those of lipopolyssacharides
in diﬀerent cyanobacteria cells (0.1−3%, d.w.),18,19 suggesting
that bartolosides may have a structural role. Bartolosides E−K
(5−11) are much less abundant than bartoloside A (1) in
S. salina LEGE 06099 cells. The structural diversity that the brt
pathway can generate in this strain is, nevertheless, noteworthy.
While some of the bartolosides are likely pathway intermediates
(i.e., those with a single halogenation, 7 and 10), shorter or
longer chain analogues indicate some relaxed speciﬁcity in DAR
formation. Previously, we have shown that BrtD accepts even-
chain fatty acyl-ACP derivativesintermediates in fatty acid
metabolismto form the DAR core of 2−4.5 According to the
proposed biosynthesis of the bartolosides,5 compounds 6 and
11 would result from the BrtD-catalyzed condensation of odd-
chain α,β-unsaturated fatty acyl-ACP thioesters (C17 and C15,
respectively) with a 3-oxo-hexadecanoyl-ACP thioester. How-
ever, neither odd-chain fatty acids nor their α,β-unsaturated
fatty acyl-ACP thioesters are known to be present in cyano-
bacteria cells.20 The closely related cyanobacterium Synechocystis
sp. PCC 6803 is known to be able to synthesize full-length odd-
chain (up to C19) saturated and unsaturated fatty acids but only
when fed with heptanoic acid.21 The fatty acid biosynthesis
machinery of this cyanobacterium can thus elongate odd-chain
precursors and generate also odd-chain α,β-unsaturated fatty
acyl-ACP thioesters. The intriguing origin of the DAR cores of
6 and 11 in S. salina LEGE 06099 will be the subject of further
study.
Bioactiviy of Monoglycosylated Bartolosides. Com-
pounds 1 and 5−11 were evaluated for their cytotoxic activity
against three diﬀerent human cancer cell lines, namely, MG-63
(bone osteosarcoma), RKO (colon carcinoma), and T-47D
(mammary gland ductal carcinoma). The bartolosides were
considered inactive (IC50 > 10 μM) against all tested cell lines.
For compounds 1 and 5 we were able to determine IC50 values
of 22 and 39 μM against MG-63 cells, 40 and 40 μM against
RKO cells, and 23 and 22 μM against T-47D cells, respectively,
and exposure to 9 revealed an IC50 of 59.8 μM in the assay with
the T-47D cell line.
■ CONCLUSION
Our report on the structures of seven new bartolosides pro-
vides a framework for the future structure elucidation of
related compounds. The structures and the biosynthesis of the
monoglycosylated bartolosides in S. salina LEGE 06099 bring
up important questions regarding the function of the encoded
glycosyltransferases and the potential involvement of odd-chain
fatty acyl derivatives. Notably, the likely role of the putative
halogenase BrtJ in carrying out a selective midchain dichlorina-
tion adds to the diﬀerent types of halogenation that have been
hypothesized for this still uncharacterized group of enzymes.
Apparently, the bartolosides do not have strong bioactive
properties; however, their high abundance inside the cells sug-
gests that these may have a fundamental biological role, which
we intend to further investigate.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations were
measured on a Jasco P-2000 polarimeter (average of 10 measurements,
589 nm) using a 1 mL sample cell, with the exception of the optical
rotation of 1 in MeCN, which was measured on an ADP410 polari-
meter (Bellingham + Stanley Ltd.), also at 589 nm. UV−vis spectra
were acquired on a Synergi HT microplate reader (BioTek) equipped
with a Take 3 plate and a quartz cuvette. IR spectra were collected
on a Jasco FT/IR 460 Plus spectrometer. NMR data were acquired in
the indicated solvents in either a 400 MHz Bruker Avance III or a
600 MHz Bruker Avance III equipped with a 5 mm cryoprobe.
Selective 1D TOCSY experiments were carried out with a magnetic
susceptibility-matched (DMSO) NMR tube (Shigemi). Acquisition of
NMR data for 1 isolated from Nodosiliena sp. LEGE 06102 was detailed
previously.5 HRESIMSn data of pure compounds were acquired on an
LTQ Orbitrap XL spectrometer, controlled by LTQ Tune Plus 2.5.5
and Xcalibur 2.1 (Thermo Scientiﬁc). The capillary voltage of the ESI
was set to −3000 V. The capillary temperature was 300 °C. The sheath
gas ﬂow rate (nitrogen) was set to 5 (arbitrary unit as provided by
the software settings). The capillary voltage was −48 V and the tube
lens voltage −247.79 V. Samples were injected at a concentration of
50 μg/mL. Selected ions were fragmented using collision-induced
dissociation (CID) with a normalized collision energy of 40%. For
the HRESIMS2 chiral recognition analysis used to determine xylose
conﬁguration, the same instrument was used, but with an ESI capillary
voltage of 3100 V, capillary temperature of 275 °C, capillary voltage of
42 V, and tube lens voltage of 85 V. Selected ions were fragmented
using CID with a normalized collision energy of 30%. The maximum
injection time for the MSn analysis and isolation width were found to be
optimal for this analysis at 50 ms and 4.0 m/z, respectively.
LC-HRESIMS proﬁles of extracts from S. salina LEGE 06099 and
S. salina LEGE 06155 were acquired in an Accela HPLC coupled to an
Accela PDA detector, Accela autosampler, and Accela 600 pump and
to an LTQ Orbitrap XL spectrometer that was operated in negative
ion mode under the conditions described above for HRESIMSn
analysis. Analytical and semipreparative-scale HPLC puriﬁcations were
carried out using a Waters 1525 binary pump, coupled to a Waters 2487
detector (monitored wavelengths: 230 and 275 nm).
All solvents used were MS-grade or HPLC-gradient grade for
MS-based experiments, HPLC gradient for HPLC analysis/puriﬁcation,
and ACS grade for extraction, VLC, ﬂash, and gravity column chromato-
graphies. NMR solvents were acquired from either Sigma-Aldrich or
BDH Prolabo (VWR).
Cyanobacterial Strains. Synechocystis salina LEGE 06099 and
S. salina LEGE 06155 were obtained from the LEGE Culture
Collection and grown at 25 °C, under a 14:10 h light (∼30 μmol
photons m−2 s−1)/dark regimen, in Z8 medium22 supplemented with
25 g L−1 NaCl and 20 μg L−1 vitamin B12.
Extraction and Isolation. Multiple cultures of S. salina LEGE
06099 were carried out in 6 L glass ﬂasks with 4 L of medium. Biomass
from a total of 120 L of culture was centrifuged (4500g, 10 min), rinsed
with deionized H2O, harvested by another round of centrifugation,
and freeze-dried to yield 15.3 g (d.w.). The biomass was extracted
by repeated percolation with a warm mixture of CH2Cl2/MeOH
(2:1, v/v). The resulting extract (2.6 g) was fractionated by normal-
phase (Si gel 60, 0.015−0.040 mm, Merck KGaA) VLC using a gradient
of increasing polarity from hexanes to EtOAc to MeOH, which yielded
nine fractions (A−I). Fraction F, eluting with 4:1 EtOAc/MeOH (v/v),
caused a marked reduction (>80%) in the viability of human cancer
cell lines RKO, MG-63, and T-47D, when tested at 100 μg/mL
(Cytotoxicity Assays subsection), and was further fractionated by gravity
column chromatography using Si gel 60 (0.040−0.063 mm, Merck
KGaA) as stationary phase and a gradient of increasing polarity from 3:7
EtOAc/Hex (v/v) to EtOAc to 1:4 MeOH/EtOAc (v/v). The resulting
subfractions were pooled according to their TLC proﬁles, and two
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adjacent subfractions (F5 and F6), eluting with 2:3 EtOAc/Hex (v/v),
contained the previously observed activity toward human cancer cell
lines. Following semipreparative HPLC separations of each of the
subfractions F5 (isocratic, 87% MeCN(aq), 3 mL/min, on a Synergi
Fusion-RP column, 250 × 10 mm, 10 μm) and F6 (85% MeCN(aq)
to 100% MeCN linear gradient over 25 min, 3 mL/min, on a Synergi
Fusion-RP column, 250 × 10 mm, 10 μm, Phenomenex), compound 1
was isolated as the main component in both subfractions (30.4 mg,
tR = 28.5 min and 12.8 mg, tR = 21.3 min, respectively, total 43.2 mg,
0.28% d.w.). The aforementioned HPLC separation of subfraction F6
also yielded a fraction (tR = 15.0−16.7 min) with 1H NMR signals that
could correspond to a bartoloside-like compound and was subjected to
analytical-scale HPLC separation (isocratic, 70% MeCN(aq), 1 mL/min,
on a Synergi Fusion-RP column, 250 × 4.6 mm, 4 μm, Phenomenex) to
yield pure 5 (0.5 mg, 0.003% d.w., tR = 39.6 min).
To obtain suﬃcient amounts of the minor halogenated compounds
present in the cells of S. salina LEGE 06099 for structure elucidation,
large-scale culturing of the cyanobacterium was carried out to yield
28.3 g of biomass (d.w.), after harvesting by centrifugation and freeze-
drying. Following organic extraction and VLC (performed as above),
fraction F contained 1H NMR signals consistent with bartoloside-
like metabolites and was further fractionated using gravity column
chromatography as detailed above. Subfractions F3, F4, and F5
contained bartoloside-like 1H NMR signals. Subfraction F3 was then
fractionated using semipreparative HPLC using a Synergi Hydro-RP
column (10 μm, 250 × 10 mm, Phenomenex). The elution was carried
out at 3 mL/min and consisted initially of isocratic conditions (87%
MeCN, aqueous) for 30 min, followed by a 5 min gradient to reach
100% MeCN, which was held for an additional 25 min. This aﬀorded
pure 1 (47.5 mg, 0.17% d.w., tR = 26.5 min), 6 (2.6 mg, 0.009% d.w.,
tR = 34.2 min), 7 (3.1 mg, 0.011% d.w., tR = 38.0 min), and 8 (4.4 mg,
0.016% d.w., tR = 38.5 min), as well as subfraction F3_3 (0.7 mg,
tR = 24.0 min), which contained a bartoloside-like metabolite (from
1H NMR analysis) among other components. The latter HPLC
subfraction was subjected to analytical-scale HPLC puriﬁcation under
isocratic conditions (90% aqueous MeCN, 1 mL/min) using a Synergi
Hydro-RP column (4 μm, 250 × 4.6 mm, Phenomenex) to aﬀord 10
(0.2 mg, 0.0007% d.w., tR = 7.5 min). Subfractions F4 and F5 (from
gravity column chromatography) were pooled based on an identical
1H NMR proﬁle and were also further processed by semipreparative
HPLC using a Synergi Fusion-RP column (10 μm, 250 × 10 mm,
Phenomenex) and an elution program with a ﬂow of 3 mL/min
consisting of isocratic conditions for 30 min with 86% MeCN(aq),
followed by a 5 min gradient to 100% MeCN, and these conditions
were held for an additional 25 min. The procedure yielded pure 1
(116.5 mg, 0.41% d.w., tR = 19.5 min), 11 (5.4 mg, 0.019% d.w., tR =
40.5 min), and a fraction that also contained bartoloside-like 1H NMR
signals, but that required further puriﬁcation. This was carried out
under analytical-scale, isocratic HPLC conditions (77% aqueous
MeCN, 1.2 mL/min) using a Synergi Fusion-RP column (4 μm,
250 × 10 mm, Phenomenex) to aﬀord 9 (0.48 mg, 0.0017% d.w.,
tR = 35.0 min).
Bartoloside A (1): white, glassy solid; [α]D
20 −31.2 (c 0.32, MeCN),
[α]D
24 −25.4 (c 0.17, CHCl3); IR (thin ﬁlm) νmax 3328, 2921, 2852,
1579, 1427, 1039 cm−1; 1H and 13C NMR data, Table S1; HRESIMS
m/z 659.3838 [M − H]− (calcd for C36H61Cl2O6, 659.3851).
Bartoloside E (5): white, glassy solid; [α]D
20 +54 (c 0.008, CHCl3);
IR (thin ﬁlm) νmax 3413, 2919, 2850, 1585 cm
−1; UV (MeOH) λmax
(log ε) 209 (4.2), 228 (3.9), 259 (3.3), 299 (2.9) nm; 1H and 13C
NMR, HMBC, and COSY data, Table 1; HRESIMS m/z 631.3517
[M − H]− (calcd for C34H57Cl2O6, 631.3538).
Bartoloside F (6): white, glassy solid; [α]D
19 (not determined,
measured value >3000); IR (thin ﬁlm) νmax 3388, 2923, 2852, 1575,
1434, 1043 cm−1; UV (MeOH) λmax (log ε) 205 (3.3), 229 (3.6), 271
(3.0) nm; 1H and 13C NMR data, Table 2; HRESIMS m/z 673.4002
[M − H]− (calcd for C37H63Cl2O6, 673.4007).
Bartoloside G (7): white, glassy solid; [α]D
21 −2.1 (c 0.12, CHCl3);
IR (thin ﬁlm) νmax 3403, 2921, 2850, 1457, 1041 cm
−1; UV (MeOH)
λmax (log ε) 205 (3.3), 229 (3.6), 272 (3.0) nm;
1H, 13C NMR data,
Table 2; HRESIMS m/z 625.4239 [M − H]− (calcd for C36H62ClO6,
625.4240).
Bartoloside H (8): white, glassy solid; [α]D
21 +0.9 (c 0.22, CHCl3);
IR (thin ﬁlm) νmax 3392, 2923, 2852, 1428, 1041 cm
−1; UV (MeOH)
λmax (log ε) 205 (3.3), 229 (3.6), 271 (3.1) nm;
1H and 13C NMR
data, Table 2; HRESIMS m/z 687.4160 [M − H]− (calcd for
C38H65Cl2O6, 687.4164).
Bartoloside I (9): white, glassy solid; [α]D
21 +22.6 (c 0.016, CHCl3);
IR (thin ﬁlm) νmax 3419, 2923, 2854, 1049 cm
−1; UV (MeOH) λmax
(log ε) 202 (3.8), 207 (4.1), 272 (3.0) nm; 1H and 13C NMR, HMBC,
and COSY data, Table 1; HRESIMS m/z 693.3454 [M − H]− (calcd
for C36H60Cl3O6, 693.3461).
Bartoloside J (10): white, glassy solid; [α]D
21 (not determined,
measured value >300); IR (thin ﬁlm) νmax 3397, 2971, 2921, 2859,
1054 cm−1; UV (MeOH) λmax 203, 226, 272 nm (molar absorptivity
not determined, very low concentration); 1H and 13C NMR data,
Table 2; HRESIMS m/z 597.3923 [M − H]− (calcd for C34H58ClO6,
597.3927).
Bartoloside K (11): white, glassy solid; [α]D
21 −9.7 (c 0.24, CHCl3);
IR (thin ﬁlm) νmax 3370, 2923, 2852, 1585, 1455, 1428, 1041 cm
−1;
UV (MeOH) λmax (log ε) 204 (2.8), 229 (3.1), 272 (2.6);
1H and 13C
NMR data, Table 2; HRESIMS m/z 645.3686 [M − H]− (calcd for
C35H59Cl2O6, 645.3694).
Sugar Conﬁguration Analysis. An MS chiral recognition
approach was used to determine the conﬁguration of the xylose
moiety and establish the identity of compound 1 isolated from S. salina
LEGE 06099. The protocol by Augusti and co-workers23 was slightly
modiﬁed, as xylose had not been used in that study. Brieﬂy, 1:1 (v/v)
aqueous MeOH solutions containing 2 mM D- or L-xylose (Sigma-
Aldrich), 2 mM N-Ac-L-Tyr (Sigma-Aldrich), and 1 mM CuSO4 were
injected onto the mass spectrometer, and the trimeric ions [Cu(N-
Ac-L-Tyr)2(D/L-Xyl)]
+ were fragmented by CID. The average relative
abundance of the dimeric ions [Cu(N-Ac-L-Tyr)2]
+ and [Cu(N-Ac-L-
Tyr)(D/L-Xyl)]+ observed in the HRESIMS2 spectra was determined
for 30 scans, so as to calculate the average relative abundance ratios
RD and RL for each sugar (RD/L = [Cu(N-Ac-L-Tyr)2]
+/[Cu(N-Ac-L-
Tyr)(D/L-Xyl)]+). A chiral discrimination factor of 1.18 (RD/RL) was
obtained. Finally, the R value obtained from a solution containing the
hydrolyzed sugar from 1 instead of the xylose standard was also
determined and compared to RD and RL. Hydrolysis of 1 (1.3 mg) had
been carried out in 2 M HCl (1 mL) at 100 °C for 1 h. After solvent
removal in vacuo, the residue was resuspended in 1.5 mL of deionized
H2O and washed twice with 1 mL of Et2O. The aqueous layer was
dried in vacuo and resuspended in 100 μL of deionized H2O (∼20 mM
xylose, assuming complete hydrolysis).
Primer Design and brtCD Ampliﬁcation and Sequencing.
Degenerate primers brtC-385F (5′ AATATGTGGCAYTCW-
GCYTCRG 3′) and brtD-596R (5′ GCATCRGAAAGCATCCA 3′)
were designed to amplify a ∼1200 bp fragment of the brtCD region
(as expected from the brt gene cluster of S. salina LEGE 06155),
by annealing to conserved regions in brtC and brtD homologues,
respectively (Figure S8). To this end, alignments of BrtC and BrtD
protein sequences that were available in GenBank were carried out
using the Geneious alignment tool in the Geneious software package
(Biomatters Limited), and strongly conserved regions identiﬁed in the
alignments; the corresponding nucleotide sequences were then used
to design the degenerate primers (Figure S8). Total genomic DNA
(gDNA) from fresh pellets of S. salina LEGE 06099 or LEGE 06155
(positive control for PCR) was isolated using a commercial kit
(Gram-negative bacteria protocol, PureLink genomic DNA mini kit,
Invitrogen). PCR ampliﬁcation using the isolated gDNAs as templates
was then carried out with the Platinum Taq high-ﬁdelity DNA poly-
merase (Invitrogen) and the two degenerate primers. A thermal cycling
protocol composed of initial denaturing at 98 °C (30 s), followed by
35 cycles of denaturing (98 °C, 10 s), annealing (55 °C, 30 s), and
elongation (72 °C, 60 s) steps and a ﬁnal elongation step (72 °C,
7 min) was used. A fragment of the expected size was visualized in an
agarose gel for both strains (Figure S8). The band corresponding to the
amplicon from S. salina LEGE 06099 was excised and puriﬁed using
a cleanup kit (Nucleospin Gel and PCR-Clean Up, Machery-Nagel).
Journal of Natural Products Article
DOI: 10.1021/acs.jnatprod.6b00351
J. Nat. Prod. 2016, 79, 2504−2513
2509
Table 1. NMR Spectroscopic Data (1H 600 MHz, 13C 150 MHz, DMSO-d6) for Compounds 5 and 9
bartoloside E (5) bartoloside I (9)
position δC, type δH (J in Hz) HMBC
a COSY no. δC, type δH (J in Hz) HMBC
a COSY
1 156.2, C 1 156.2, C
2 115.8, C 2 115.8, C
3 155.6, C 3 155.6, C
3-OH 8.99, s 2, 3 3-OH 9.00, d (2.7) 2, 3
4 109.0, CH 6.29, s 2, 3, 6, 24 24 4 109.0, CH 6.29, s 2, 3, 6, 24
5 140.3, C 5 140.3, C
6 106.2, CH 6.31, s 1, 2, 4, 24 24 6 106.1, CH 6.31, s 1, 2, 4, 24
7 101.8, CH 4.70, d (7.2) 1 8 7 101.8, CH 4.70, d (6.9) 8
8 73.3, CH 3.20, m 7, 9 7, 8-OH 8 73.3, CH 3.21, m 7 7, 8-OH
8-OH 5.16, d (5.1) 8, 9 8 8-OH 5.17, t (5.2) 8, 9 8
9 76.6, CH 3.20, m 8 9-OH 9 76.6, CH 3.20, m 9-OH
9-OH 5.04, d (3.3) 9 9-OH 5.04, d (2.8) 10 9
10 69.4, CH 3.35, m 8 10-OH, 11a,
11b
10 69.4, CH 3.35, m 10-OH, 11a,
11b
10-OH 5.01, d (4.9) 9, 11 10 10-OH 5.01, d (4.9) 11 10
11a 65.6, CH2 3.71, dd (11.2,
5.3)
7, 9, 10 10, 11b 11a 65.6, CH2 3.72, dd (11.3,
5.3)
7 10, 11b
11b 3.16, dd (∼11.1) 7 10, 11a 11b 3.16, dd (∼10.6) 9 10, 11a
12a 22.5, CH2 2.54, m 1, 2, 3, 13 12b, 13 12a 22.5, CH2 2.54, m 2 12b, 13
12b 2.46, m 1, 2, 3, 13 12a, 13 12b 2.47, m 2 12a, 13
13 28.8, CH2 1.40, m 12a, 12b 13 28.7, CH2 1.40, m 12a, 12b
14 29.0−28.5, CH2 1.29−1.24, m 15, 16 14 29.0−28.3, CH2 1.30−1.24, m
15a 26.0−25.6, CH2 1.45−1.43, m 15b, 16a, 16b 15a 25.9−25.6, CH2 1.45−1.43, m 15b, 16a, 16b
15b 1.36−1.34, m 15a, 16a, 16b 15b 1.36−1.34, m 14 15a, 16a, 16b
16a 37.9−37.8, CH2 1.72−1.70, m 15a, 15b, 16b,
17
16a 37.9−37.8, CH2 1.72−1.70, m 15a, 15b, 16b,
17
16b 1.63−1.60, m 17 15a, 15b, 16a,
17
16b 1.63−1.60, m 17 15a, 15b, 16a,
17
17 64.9−64.8, CH 4.01, m 16a, 16b, 18a,
18b
17 64.9, CH 4.01, m 16a, 16b, 18a,
18b
18a 37.9−37.8, CH2 1.72−1.70, m 17, 18b, 19a,
19b
18a 37.9−37.8, CH2 1.72−1.70, m 17, 18b, 19a,
19b
18b 1.63−1.60, m 17 17, 18a, 19a,
19b
18b 1.63−1.60, m 17 17, 18a, 19a,
19b
19a 26.0−25.6, CH2 1.45−1.43, m 18a, 18b, 19b 19a 25.9−25.6, CH2 1.45−1.43, m 18a, 18b, 19b
19b 1.36−1.34, m 22 18a, 18b, 19a 19b 1.36−1.34, m 20 18a, 18b, 19a
20 29.0−28.5, CH2 1.29−1.24, m 18, 19, 21, 22,
23
20 29.0−28.3, CH2 1.30−1.24, m 21
21 30.7, CH2 1.25, m 22, 23 21 30.7, CH2 1.30, m 20, 22 23
22 22.0, CH2 1.28, m 19, 20, 21, 23 23 22 22.0−21.9, CH2 1.28, m 23 23
23 13.9, CH3 0.86, t (6.9) 21, 22 22 23 13.9−13.8, CH3 0.86, t (7.2) 21, 22 21, 22
24 35.1, CH2 2.40, t (7.7) 4, 5, 6, 25, 26 4, 6, 25 24 35.1, CH2 2.40, m 4, 5, 6, 25 25
25 30.7, CH2 1.49, m 24, 26 24, 26 25 30.6, CH2 1.50, m 26 24, 26
26 28.3, CH2 1.27, m 25, 27, 28 25 26 28.2
b, CH2 1.31, m 25, 27
27 29.0−28.5, CH2 1.29−1.24, m 25, 26, 28, 29 27 24.8−24.5, CH2 1.57, m 26, 28, 30 26, 28
28a 26.0−25.6, CH2 1.45−1.43, m 28b, 29a, 29b 28 47.2−47.1, CH2 2.19, m 27, 29, 30,
31
27
28b 1.36−1.34, m 28a, 29a, 29b 29 97.2, C
29a 37.9−37.8, CH2 1.72−1.70, m 28a, 28b, 29b,
30
30 47.2−47.1, CH2 2.19, m 27, 28, 29,
31
31
29b 1.63−1.60, m 30 28a, 28b, 29a,
30
31 24.8−24.5, CH2 1.57, m 28, 30 30
30 64.9−64.8, CH 4.01, m 29a, 29b, 31a,
31b
32 29.0−28.3, CH2 1.30−1.24, m 33
31a 37.5, CH2 1.72−1.70, m 30, 31b 33 29.0−28.3, CH2 1.30−1.24, m 32
31b 1.63−1.60, m 30 30, 31a 34 31.1, CH2 1.26, m 33 36
32a 28.1, CH2 1.41, m 35 22.0−21.9, CH2 1.28, m 36 36
32b 1.31, m 36 13.9−13.8, CH3 0.86, t (7.2) 34, 35 34, 35
33 21.7, CH2 1.28, m 31, 32, 34 34
34 13.9, CH3 0.87, t (7.3) 32, 33 33
aFrom proton to the indicated carbon. bFrom HSQC-TOCSY data.
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The puriﬁed amplicon was ligated to a pGEM-T Easy Vector (Promega)
using T4 DNA ligase and the resulting construct was cloned onto
chemically competent E. coli TOP10 cells (Life Technologies), puriﬁed
from a 5 mL culture of transformed E. coli cells (GenElute plasmid
miniprep kit, Sigma-Aldrich), and sequenced using M13 primers by
Sanger Technology (GATC Biotech). The resulting sequence showed
high similarity (82% identity) to a portion of the brtCD region from
S. salina LEGE 06155.5
Genome Sequencing, Identiﬁcation, and Annotation of the
brt Gene Cluster. Total genomic DNA was isolated from a fresh
pellet of a S. salina LEGE 06099 culture using a CTAB-chloroform/
isoamyl alcohol-based protocol.24 The gDNA was ﬁrst fragmented
using the AB Library Builder System (Applied Biosystems) and
subsequently submitted for sequencing on the Ion Torrent PGM
(ThermoFisher Scientiﬁc) platform. After sequencing, the reads were
evaluated for quality using FastQC25 followed by assembling with
SPAdes version 3.7.0.26 Using the BLAST algorithm and the Geneious
software package, the generated contigs were queried with the PCR-
derived brtCD sequence obtained from S. salina LEGE 06099 (see
above), which was found (100% identity) within a 106.5 kb contig.
The genomic context of these genes was annotated manually, by using
the predicted ORFs as queries in blast searches against the NCBI
nucleotide and protein databases (Table S2). The boundaries of the
brt gene cluster were deﬁned by the high similarity of ﬂanking genes to
the genomes of the closely related Synechocystis sp. strains PCC 6803
and PCC 6714 (Table S2). The annotated nucleotide data have been
deposited in GenBank under accession number KX083339.
Cytotoxicity Assays. The evaluation of the cytotoxic activity of
chromatographic fractions and pure compounds was performed on the
human cancer cell lines T47D (breast carcinoma cells), RKO (colon
carcinoma cells), and MG-63 (osteosarcoma cells) at 30 μg/mL
(fractions) or dilutions from 50 to 0.003 μg/mL (pure compounds).
IC50 values were determined from dose−response curves using the
software GraphPad Prism v6.0 (GraphPad Software). Cells were
cultured in Dulbecco’s modiﬁed Eagle medium (DMEM Glutamax,
Gibco), supplemented with 10% (v/v) fetal bovine serum (Gibco),
2.5 μg/mL fungizone (Gibco), 100 IU/mL penicillin, and 100 μg/mL
streptomycin (Pen.Step, Gibco). Cells were preinoculated for 24 h
(37 °C; 5% CO2) in 96-well plates at a concentration of 3.3 ×
104 cells/mL for cell adhesion. An exposure to the fractions and
compounds was then carried out for 48 h. For the determination of
cell viability, exposed cells were incubated for 3 h with 0.5 mg/mL
MTT, and the resulting purple-colored formazan salts were dissolved
in 100 μL of DMSO. The absorbance was measured at 550 nm in a
microplate reader (Synergi HT, Biotek). All tests were run in triplicate
and averaged.
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